Home › Stocks › DRMA

DRMA — DERMATA THERAPEUTICS INC

Reported value held$804.37K
Funds holding (latest)31
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)15
Institutional value$186.81K · 170.14K sh
New / Add / Cut / Exit7 / 2 / 3 / 5 · Updated 2026-11-17
Top-5 / Top-10 concentration65.2% / 99.7%
Institutional holdings change Reducing -6.9% (-5.24K sh)
Institutional value change Down -20.6%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — 54.1% -3805.7% — — — —

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingStrong Buy
Analysts covering2
12-month price target$4.00 (+637.3%)
Last price at fetch$0.54
Forward P/E (FY1)—
Forward P/E (FY2)—
Revision score (quarter)—
Revision score (year)—

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 15 SEC-registered investment managers reported holding DRMA (DERMATA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $186.81K across 170.14K shares. That is -6.9% by share count (-5.24K shares) versus the previous quarter, while reported value moved -20.6%. Ownership is concentrated: the five largest holders account for 65.2% of reported value and the top ten for 99.7%.

Compared with the prior quarter, 7 opened new positions, 2 added to existing stakes, 3 trimmed, 5 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of DERMATA THERAPEUTICS INC (DRMA) include ARMISTICE CAPITAL, LLC, Clear Street Group Inc., Citadel Advisors, ranked by reported 13F value among the 31 institutional holders on this page.

DRMA is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 15 170.14K $186.81K -6.9%
Q2 2026 13 123.97K $159.92K -41.1%
Q1 2026 7 106.49K $128.85K +991.5%
Q4 2025 7 26.89K $62.39K -35.8%
Q3 2025 5 92.23K $463.00K -78.0%
Q2 2025 10 508.15K $297.50K -11.2%
Q1 2025 8 518.51K $561.19K +967.7%
Q4 2024 6 45.53K $61.47K +168.9%

Over the 8 quarters shown, institutional share counts increased 274% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (+991.5%).

Top Institutional Holders (Q3 2026) — 15 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 32.80K $36.08K 0.00% New
Geode Capital Management 20.10K $22.11K 0.00% Reduce
WELCH & FORBES LLC 20.00K $22.00K 0.00% Hold
HRT FINANCIAL LP 19.40K $21.00K 0.00% New
STATE STREET CORP 18.75K $20.62K 0.00% New
UBS Group AG 17.11K $18.83K 0.00% Add
JANE STREET GROUP, LLC 16.59K $18.25K 0.00% New
XTX Topco Ltd 12.88K $14.16K 0.00% Reduce
Citigroup Inc 6.62K $7.29K 0.00% New
VANGUARD CAPITAL MANAGEMENT LLC 5.44K $5.98K 0.00% New
Tower Research Capital LLC (TRC) 313 $344 0.00% Reduce
SBI Securities Co., Ltd. 102 $112 0.00% Add
HIGHLINE WEALTH PARTNERS LLC 26 $29 0.00% Hold
JPMorgan Chase & Co 3 $3 0.00% New
Morgan Stanley 2 $2 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 13 funds

FundSharesValuePortfolio WeightChange
GEODE CAPITAL MANAGEMENT, LLC 20.20K $26.06K 0.00% New
Geode Capital Management 20.20K $26.06K 0.00% Reduce
WELCH & FORBES LLC 20.00K $25.80K 0.00% Hold
UBS Group AG 16.80K $21.67K 0.00% Reduce
SUSQUEHANNA INTERNATIONAL GROUP, LLP 15.99K $20.63K 0.00% New
XTX Topco Ltd 14.79K $19.07K 0.00% New
Advisory Alpha, LLC 10.00K $12.90K 0.00% New
Tower Research Capital LLC (TRC) 3.86K $4.98K 0.00% Add
MCF Advisors LLC 1.73K $2.23K 0.00% Hold
BARCLAYS PLC 270 $348 0.00% New
SBI Securities Co., Ltd. 101 $130 0.00% Hold
HIGHLINE WEALTH PARTNERS LLC 26 $34 0.00% New
Morgan Stanley 2 $3 0.00% New

Q1 2026 — 7 funds

FundSharesValuePortfolio WeightChange
Geode Capital Management 48.33K $58.48K 0.00% New
UBS Group AG 35.61K $43.09K 0.00% Add
WELCH & FORBES LLC 20.00K $24.20K 0.00% New
MCF Advisors LLC 1.73K $2.10K 0.00% New
Tower Research Capital LLC (TRC) 716 $866 0.00% Reduce
SBI Securities Co., Ltd. 101 $122 0.00% Hold
Citigroup Inc 1 $1 0.00% New

Q4 2025 — 7 funds

FundSharesValuePortfolio WeightChange
Clear Street Group Inc. 17.00K $39.44K 0.00% New
Bank of America Corp 3.46K $8.02K 0.00% Add
BARCLAYS PLC 2.40K $5.57K 0.00% New
Tower Research Capital LLC (TRC) 2.00K $4.64K 0.00% Add
UBS Group AG 1.24K $2.87K 0.00% Reduce
JPMorgan Chase & Co 696 $1.61K 0.00% New
SBI Securities Co., Ltd. 101 $234 0.00% Hold

Q3 2025 — 5 funds

FundSharesValuePortfolio WeightChange
ARMISTICE CAPITAL, LLC 81.65K $409.90K 0.01% Reduce
UBS Group AG 10.05K $50.44K 0.00% Reduce
Tower Research Capital LLC (TRC) 426 $2.14K 0.00% Reduce
SBI Securities Co., Ltd. 101 $507 0.00% Reduce
Bank of America Corp 4 $20 0.00% Reduce

Q2 2025 — 10 funds

FundSharesValuePortfolio WeightChange
ARMISTICE CAPITAL, LLC 322.18K $188.47K 0.00% Reduce
UBS Group AG 90.95K $53.21K 0.00% Add
XTX Topco Ltd 34.49K $20.18K 0.00% New
Geode Capital Management 27.39K $16.02K 0.00% Add
TWO SIGMA SECURITIES, LLC 14.72K $8.61K 0.00% New
JONES FINANCIAL COMPANIES LLLP 12.00K $7.25K 0.00% Hold
Tower Research Capital LLC (TRC) 5.32K $3.11K 0.00% Add
SBI Securities Co., Ltd. 1.01K $591 0.00% Add
Citigroup Inc 60 $35 0.00% New
Bank of America Corp 31 $18 0.00% Add

View all 31 fund holders →

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Citadel Advisors 32.80K — — — — — — — — — 17.49K — — 17.19K — — — 79.97K — —
Geode Capital Management 20.10K 20.20K 48.33K — — 27.39K 20.41K — — — 12.24K 12.24K 12.24K — — 26.67K 26.67K 26.67K 26.67K 26.67K
WELCH & FORBES LLC 20.00K 20.00K 20.00K — — — — — — — — — — — — — — — — —
HRT FINANCIAL LP 19.40K — — — — — — — — — — — — — — — — — — —
STATE STREET CORP 18.75K — — — — — — — — — — — — — — — — — — —
UBS Group AG 17.11K 16.80K 35.61K 1.24K 10.05K 90.95K 70.29K 13.87K 1.50K 1.71K — — 131 7.01K 3.44K 37.31K 14.80K 11.21K 4.32K —
JANE STREET GROUP, LLC 16.59K — — — — — — — — — — — — — — — — — — —
XTX Topco Ltd 12.88K 14.79K — — — 34.49K — — — — — — — — — — — — — —
Citigroup Inc 6.62K — 1 — — 60 — — — — — — — — — — — 48.94K — —
VANGUARD CAPITAL MANAGEMENT LLC 5.44K — — — — — — — — — — — — — — — — — — —
Tower Research Capital LLC (TRC) 313 3.86K 716 2.00K 426 5.32K 1.80K 1.39K 2.89K 1.73K 5.74K 6.42K 5.14K — — — — — — —
SBI Securities Co., Ltd. 102 101 101 101 101 1.01K 1.00K 1.00K — — — — — — — — — — — —
HIGHLINE WEALTH PARTNERS LLC 26 26 — — — — — — — — — — — — — — — — — —
JPMorgan Chase & Co 3 — — 696 — — — — — — — — — — — — — — 569 12.14K
Morgan Stanley 2 2 — — — — — — — — — — — — — 562 — — 3 500
ARMISTICE CAPITAL, LLC — — — — 81.65K 322.18K 411.00K 27.20K — 28.00K — 218.00K — — — — — — — —
Renaissance Technologies — — — — — — — — — — — — — — 26.40K — — — — 39.25K
Clear Street Group Inc. — — — 17.00K — — — — — — — — — — — — — — — —
GEODE CAPITAL MANAGEMENT, LLC — 20.20K — — — — — — — — — — — — — — — — — —
SUSQUEHANNA INTERNATIONAL GROUP, LLP — 15.99K — — — — — — — — — — — — — — — — — —

Download holders (CSV)

FAQ

Which funds hold DRMA?

As of 2026-Q3, 15 institutional funds reported holding DRMA (DERMATA THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $186.81K.

How many shares of DRMA do institutions own?

13F filers reported 170.14K shares of DRMA, worth $186.81K in aggregate at the end of 2026-Q3.

Is institutional ownership of DRMA rising or falling?

Share counts moved -6.9% versus the prior quarter — distribution.

Who are the top institutional holders of DRMA?

The largest 13F holders are ARMISTICE CAPITAL, LLC, Clear Street Group Inc., Citadel Advisors, Renaissance Technologies, Two Sigma Investments; the top 25 are ranked at the top of this page.

Who are the major shareholders of DERMATA THERAPEUTICS INC?

The major shareholders of DERMATA THERAPEUTICS INC (DRMA) by reported 13F value are ARMISTICE CAPITAL, LLC, Clear Street Group Inc., Citadel Advisors, Renaissance Technologies, Two Sigma Investments, among 31 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own DRMA" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/DRMA/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →